USANA Health Sciences, Inc. announced that Jim Brown will succeed Kevin Guest, who will transition to Executive Chairman of the Company on the effective July 1, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.44 USD | -0.59% | -1.56% | -15.22% |
05-07 | DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating | MT |
05-01 | Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.22% | 866M | |
+13.09% | 8.12B | |
+0.47% | 7.26B | |
-6.90% | 5.5B | |
-7.83% | 3.65B | |
-16.56% | 3.33B | |
-11.70% | 1.21B | |
-24.90% | 1.15B | |
+4.24% | 899M | |
-11.98% | 845M |
- Stock Market
- Equities
- USNA Stock
- News USANA Health Sciences, Inc.
- Usana Health Sciences, Inc. Appoints Kevin Guest as Executive Chairman